Verastem Announces Positive Top-line Data from the Pivotal Phase 3 DUO ™

... Read more

Vericel Announces Positive Top-Line Results From Phase 2b ixCELL-DCM Clinical

... Read more

FDA Approves MACI for the Treatment of Symptomatic Cartilage Defects of the

... Read more

Vericel Reports Fourth Quarter and Year End 2017 Financial Results and

... Read more

Verint Announces First Quarter Results

... Read more

Versartis Announces

... Read more

Vertex Energy, Inc. Announces Second Quarter 2015 Financial Results

... Read more

Vertex Energy, Inc.

... Read more

Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements

... Read more

TTM

... Read more